Updates from The Motley Fool

Latest updates on Celgene from Fool.com.

Stock Performance

CELG vs. S&P 500 | 2 Year Performance
CELG 1-Day Stock Chart
CELG 5-Day Stock Chart
CELG 1-Month Stock Chart
CELG 3-Month Stock Chart
CELG 6-Month Stock Chart
CELG 1-Year Stock Chart
CELG 2-Year Stock Chart
CELG 5-Year Stock Chart
View Interactive CELG Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $101.09
Prev Close: $100.90
Open: $100.82
Bid: $100.73
Ask: $100.80
Day's Range: $99.98 - $101.51
52wk Range: $92.98 - $140.72
Volume: 408,187
Avg Vol 4,725,539
Market Cap: $79.42B
P/E (ttm): 48.74
EPS (ttm): $2.07
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
2123 Outperform
76 Underperform
CAPS All Stars
418 Outperform
11 Underperform

How do you think Celgene will perform against the market?

You pick for Celgene is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark J. Alles, CEO

100% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers